Heroin-assisted treatment

Heroin-assisted treatment

Classification
External resources

{{This medical treatment related article is a stub. You can help WikiMD by expanding it.}}

Heroin-assisted treatment (HAT), also known as diacetylmorphine-assisted treatment, is a medical treatment for individuals who are addicted to opioids. This treatment involves the controlled administration of pharmaceutical-grade heroin under the supervision of medical staff. HAT is typically used when other forms of medication-assisted treatment, such as methadone or buprenorphine, have not been successful.

Overview

Heroin-assisted treatment is aimed at people who have not benefited from traditional methods of opioid addiction treatment. These individuals often continue to use illicit drugs, engage in criminal activity, or suffer from health issues related to drug use. HAT provides them with a safer alternative to illicit heroin use, reducing the risk of overdose and the spread of diseases such as HIV/AIDS and hepatitis through contaminated needles.

Efficacy

Studies have shown that heroin-assisted treatment can lead to reductions in illicit drug use, improvements in health and social functioning, and a decrease in criminal activity among participants. It is considered a harm reduction strategy, focusing on minimizing the negative consequences associated with drug use.

Implementation

Heroin-assisted treatment is legally and medically regulated and is only available in some countries, such as Switzerland, Germany, and Canada. In these countries, HAT is provided in specialized clinics, and patients are closely monitored during treatment.

Controversy

The use of heroin in treatment is controversial. Critics argue that it may perpetuate addiction and send a mixed message about drug use. Proponents, however, argue that heroin-assisted treatment is a pragmatic approach to treating severe addiction, particularly in cases where other treatments have failed.

See also

• Drug policy
• Harm reduction
• Opioid epidemic